Fang previously worked within Roche’s business development & licensing organization in the U.S. and Europe. He brings relevant skills and experience sourcing new opportunities and leading transactions across the fields of oncology, immunology, infectious and rare diseases. In his most recent role as Director, Global Oncology and Immuno-Oncology Business Development & Licensing, he was intimately involved in constructing an innovation strategy for cancer immunology and the molecular targeted therapy landscapes.